KD Market Insights has published a
new report on global Antisense Oligonucleotides market analysis and forecast
2019-2024. The report comprises of global Antisense Oligonucleotides market
size, Y-o-Y growth analysis, and market dynamics, including growth drivers,
restraining factors, opportunities, and trends which are spearheading current
nature and future status of the market.
Global Antisense Oligonucleotides market
witnessed a market value of USD XX Million in 2019 and is estimated to reach
USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX%
between 2019 and 2024. The report analyses the market by geographies i.e. North
America, Europe, Asia Pacific, Latin America & Middle East & Africa.
Further, the geographies are fragmented into the country and regional
groupings:
The market research report
provides a thorough analysis of the industry trends, market opportunities,
growth drivers which would help the investors to create and align their market
strategies according to the current and future market dynamics.
The report is sub-segmented Based on Drugs: -
Pegaptanib, Eteplirsen, Mipomersen, Others. Based on
Therapeutic Application: - Cancer, Diabetes, Ocular diseases,
Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy,
Hemorrhagic fever viruses, HIV/AIDS, Cytomegalovirus retinitis, Others. Based
on Distribution Channel: - Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies.
Geographically, the report
provides an exhaustive analysis of geographical scenario of the market delivers
detailed analysis including market size, share, year on year growth and
opportunity analysis about the five major geographies including North America,
Europe, Asia Pacific, Latin America and Middle East & Africa. Further, the
regions are segmented into countries:
·
North
America (U.S. & Canada)
·
Europe
(Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
·
Asia
Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New
Zealand and Rest of Asia Pacific)
·
Latin
America (Brazil, Mexico, Argentina and Rest of Latin America)
·
Middle
East & Africa (GCC, North Africa, South Africa and Rest of Middle East
& Africa)
Some of major Antisense Oligonucleotides market
players are - Ionis Pharmaceuticals Inc., Sarepta Therapeutics Inc., Biogen
Inc., Alnylam Pharmaceuticals Inc., Antisense Therapeutics Ltd., Isarna
Therapeutics GmbH, Arrowhead Pharmaceuticals Inc., Atlantic pharmaceuticals
Inc., Enzon Pharmaceuticals Inc., Bio-Path Holdings Inc., Glaxo smith Kline
Plc., Gene Signal International SA., Geron Corporation, Gradlis Inc., Other
Major & Niche Key Players.
This report provides detailed analysis of the
company’s business and financial performance such as net revenue, sales split
by segment and by region, SWOT Analysis, company overview, business strategy,
product offerings, recent news & development and other major events. The
report also analyzes company’s positioning and market share in Antisense
Oligonucleotides Market.
key features of the market research report
include:
·
The
report provides a basic overview of the market including its definition, market
maturity analysis, porters five force analysis and value chain analysis
·
The
report presents market dynamics which includes market drivers and restraints,
industry trends, and market opportunities.
·
The
report provides market size for 2018, preliminary estimate for 2019 and
forecast for 2019-2024.
·
The
total market is further divided and analyzed by geographies and countries
·
An
all-inclusive data for segment market analysis by market segment on the basis
of Based
on Drugs, Based on Therapeutic Application, Based on Distribution Channel.
·
The
report also offers market share of major players, and detailed company profile.
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/5525/antisense-oligonucleotides-market
Table Of Content:
1. Preface
1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process
and Design
1.1.2.1. Secondary
Research
1.1.2.2. Key Sources and
Use of Primary Research
1.1.2.3. Market Size
Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of
the Study
1.5. Assumptions and
Limitations for Market Estimation and Forecasting
2. Executive Summary
2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Antisense
Oligonucleotides Market Trends for 2019
3. Porter’s Five Force
Analysis
3.1. Threat of Substitutes
3.2. Bargaining Power of
Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New
Entrants
3.5. Degree of Competition
4. Manufacturing Cost
Structure Analysis
4.1. Raw Material and
Suppliers
4.2. Industry Chain
Structure of Antisense Oligonucleotides
4.3. Manufacturing Process
Analysis of Antisense Oligonucleotides
4.4. Manufacturing Cost
Structure Analysis of Antisense Oligonucleotides
5. Manufacturing Plants
Analysis of Antisense Oligonucleotides
5.1. Capacity and
Production
5.2. Global Antisense
Oligonucleotides Manufacturing Plants Distribution
5.3. Recent Development
and Expansion Plans
6. Competitive
Landscape
6.1. Global Antisense
Oligonucleotides Market 2018
6.2. Global Antisense
Oligonucleotides Market Value Share, By Company 2018
6.3. Global Antisense
Oligonucleotides Market Volume Share, By Company 2018
7. Market Dynamics
7.1. Growth Drivers &
Barriers in Antisense Oligonucleotides Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in
Antisense Oligonucleotides Market
8. Global Antisense Oligonucleotides
Market
8.1. Introduction
8.2. Key Trends &
Growth Drivers
8.3. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9. Global Antisense
Oligonucleotides Market Segmentation Analysis, By Drugs
9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By
Drugs
9.2.2. Market
Attractiveness, By Drugs
9.3. Pegaptanib
9.3.1. Key Trends &
Growth Drivers
9.3.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Eteplirsen
9.4.1. Key Trends &
Growth Drivers
9.4.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5. Mipomersen
9.5.1. Key Trends &
Growth Drivers
9.5.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6. Others
9.6.1. Key Trends &
Growth Drivers
9.6.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10. Global Antisense
Oligonucleotides Market Segmentation Analysis, By Therapeutic Application
10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By
Therapeutic Application
10.2.2. Market
Attractiveness, By Therapeutic Application
10.3. Cancer
10.3.1. Key Trends &
Growth Drivers
10.3.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Diabetes
10.4.1. Key Trends &
Growth Drivers
10.4.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5. Ocular diseases
10.5.1. Key Trends &
Growth Drivers
10.5.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.6. Amyotrophic Lateral
Sclerosis (ALS)
10.6.1. Key Trends &
Growth Drivers
10.6.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.6.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.7. Spinal Muscular
Atrophy
10.7.1. Key Trends &
Growth Drivers
10.7.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.7.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.8. Hemorrhagic fever
viruses
10.8.1. Key Trends &
Growth Drivers
10.8.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.8.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.9. HIV/AIDS
10.9.1. Key Trends &
Growth Drivers
10.9.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.9.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.10. Cytomegalovirus retinitis
10.10.1. Key Trends &
Growth Drivers
10.10.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.10.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.11. Others
10.11.1. Key Trends &
Growth Drivers
10.11.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.11.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
Continue:
About Us:
KD Market Insights is one of the leading providers of market
intelligence products and services. We offer reports on over 10+ industries and
update our collection daily which helps our clients to access database of
expert market insights on global industries, companies, products, and trends.
Our in-house research experts have a wealth of
knowledge in their respective domains. With KD Market Insights, you always have
the choice of getting customized report free of cost (upto 10%). Our support
team will help you customize the report and scope as per your business needs.
This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500
companies and leading advisory firms.
Contact Us:
KD Market Insights
90 State Street, Albany,
New York, USA 12209
+1 (518) 300-1215
